Literature DB >> 2984282

Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis).

G Tosato, S Straus, W Henle, S E Pike, R M Blaese.   

Abstract

We evaluated immune functions in 16 patients with chronic active Epstein-Barr virus (EBV) infection (chronic infectious mononucleosis). Chronic infectious mononucleosis is an illness characterized primarily by chronic and occasionally disabling fatigue and other constitutional complaints, only sometimes beginning with an episode of acute infectious mononucleosis, and associated with an abnormal pattern of serum antibodies to EBV. In these patients, the frequency of circulating EBV-infected B cells that manifested spontaneous outgrowth in vitro was comparable to that found in EBV-seropositive normals, and the levels of EBV-specific suppressor activity were also normal. Upon stimulation with polyclonal activators, unseparated cells from these patients produced a relatively normal number of immunoglobulin-secreting cells. However, when purified T cells from these patients were mixed with normal mononuclear cells in co-culture, immunoglobulin production was strikingly suppressed. The degree of this T cell suppression correlated directly with the abnormally elevated titer of antibody to the early antigens of EBV. Interestingly, during normal convalescence from acute EBV-induced infectious mononucleosis a period is also seen during which T cells suppress the response of allogeneic but not autologous cells. Thus, from an immunologic viewpoint, patients with chronic active EBV infection appear "frozen" in a state typically found only briefly during the convalescence from acute EBV infection.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2984282

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

Review 1.  Relationship between antibody production to Epstein-Barr virus (EBV) early antigens and various EBV-related diseases.

Authors:  T Ooka; M de Turenne-Tessier; M C Stolzenberg
Journal:  Springer Semin Immunopathol       Date:  1991

Review 2.  Adoptive immunotherapy for Epstein-Barr virus-associated lymphoproliferative disorders complicating marrow allografts.

Authors:  R J O'Reilly; T N Small; E Papadopoulos; K Lucas; J Lacerda; L Koulova
Journal:  Springer Semin Immunopathol       Date:  1998

3.  Immunologic abnormalities in chronic fatigue syndrome.

Authors:  N G Klimas; F R Salvato; R Morgan; M A Fletcher
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

4.  Chronic Fatigue Syndrome: Do herbs or homeopathy help?

Authors:  E Leyton; H Pross
Journal:  Can Fam Physician       Date:  1992-09       Impact factor: 3.275

5.  Chronic fatigue syndrome.

Authors:  R Holland
Journal:  CMAJ       Date:  1989-05-01       Impact factor: 8.262

6.  Chronic fatigue syndrome.

Authors: 
Journal:  CMAJ       Date:  1989-02-15       Impact factor: 8.262

7.  Chronic Epstein-Barr virus syndrome.

Authors:  J F Jones
Journal:  Bull N Y Acad Med       Date:  1988 Jul-Aug

8.  Retroviral sequences related to human T-lymphotropic virus type II in patients with chronic fatigue immune dysfunction syndrome.

Authors:  E DeFreitas; B Hilliard; P R Cheney; D S Bell; E Kiggundu; D Sankey; Z Wroblewska; M Palladino; J P Woodward; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1991-04-01       Impact factor: 11.205

9.  Lymphocyte phenotype and function in the chronic fatigue syndrome.

Authors:  S E Straus; S Fritz; J K Dale; B Gould; W Strober
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

10.  Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infection.

Authors:  H Kimura; I Tsuge; S Imai; M Yamamoto; K Kuzushima; T Osato; T Morishima
Journal:  Med Microbiol Immunol       Date:  1995-08       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.